Our laboratory is focused on identifying and characterizing novel pathways in the kidney podocyte that are critical to the pathogenesis of glomerulosclerosis. Read More
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice
May 17, 2013 - The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.
Lewis Kaufman, MD
1468 Madison Avenue
23rd Floor, Room 23-76 (Lab)
New York, NY 10029